Special Drug Use-results survey for long-term administration of Stelara

Special Drug Use-results survey for long-term administration of Stelara - Special Drug Use-results survey for long-term administration of Stelara

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015899

Enrollment

1500

Registered

2014-12-15

Start date

2011-03-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis vulgaris, psoriatic arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with psoriasis vulgaris or psoriatic arthritis who do not have adequate response to conventional treatments in actual medical practice

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Safety(Adverse Drug Reaction) Effectiveness(Psoriasis Area and Severity Index(PASI))	—

Countries

Japan

Contacts

Public ContactYuko Kojima

Janssen Pharmaceutical K.K. Safety Risk Management Dept.

ykojima4@its.jnj.com03-4411-5437

Outcome results